Autres langues T2 Biosystems, Inc.

Actions

TTOO

US89853L3024

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
3,72 ^USD	+1,92%		+30,99%	-40,72%

29/04	T2 BIOSYSTEMS, INC. : Canaccord Genuity toujours neutre sur le dossier	ZM
01/04	T2 Biosystems, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	24/04
Top Premarket Decliners	23/04
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	11/04
T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	28/03
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc	28/03
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Year 2024	20/03
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20/03
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20/03
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	19/03
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	18/03
T2 Biosystems, Inc. Announces Publication of New Study Highlighting Clinical Benefits and Performance of Real-World Use of T2Resistance Panel in Journal of Clinical Microbiology	18/03
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	12/03
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	15/02
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	15/02
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	15/02
T2 Biosystems, Inc. Announces Commercial Expansion Through Distributors in Europe and Asia	15/02
Sector Update: Health Care Stocks Mixed Late Afternoon	12/02
Sector Update: Health Care Stocks Steady in Afternoon Trading	12/02
T2 Biosystems Gets FDA Clearance for Expanded T2Bacteria Panel; Shares Rise	12/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues T2 Biosystems, Inc.

Actions

TTOO

US89853L3024

Autres langues

Filtres